Sector valuations Charles River Laboratories International, Inc. Berne S.E.
Stocks
RV6
US1598641074
Biotechnology & Medical Research
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 186.86 CHF | +0.90% |
|
+0.39% | - |
| 07-29 | Align Technology to add directors, launch review after deal with Elliott | RE |
| 07-20 | Analyst recommendations: Global Payments, Charles Schwab, US Bancorp, Datadog, Netflix… |  |
Main competitors
| P/E (N) | Price to Book (N) | PEG (N) | EV / Sales (N) | EV / EBITDA (N) | EV / EBIT (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
 | 32.83x | 4.39x | 1.23x | 5.9x | 17.55x | 24.59x | 0.98% | 48.53B | |
| -23.41x | 18.35x | -0.68x | 351.08x | -21.45x | -21.37x | -.--% | 39.87B | |
| 30.42x | 5.61x | -20.69x | 3.04x | 13.11x | 20.09x | -.--% | 38.68B | |
| 46.94x | 7.06x | 0.28x | 4.76x | 30.78x | 35.58x | -.--% | 35.13B | |
| 28.41x | 2.31x | 0.59x | 8.22x | 20.66x | 24.61x | 0.41% | 29.79B | |
| 32.82x | 23.55x | 2.18x | 5.37x | 24.39x | 25.51x | -.--% | 16.11B | |
| 22.67x | 2.54x | 0.65x | 2x | 8.67x | 13.3x | 1.17% | 13.61B | |
| 25.02x | 1.32x | 0.2x | 1.86x | 11.41x | 12.99x | -.--% | 12.62B | |
| 61.88x | 5.18x | 0.4x | 9.24x | 26.25x | 28.67x | 0.44% | 11.24B | |
| -29.97x | 8.82x | 1.13x | 107.59x | -30.62x | -53.29x | -.--% | 10.54B | |
| -31.07x | 8.99x | -13.64x | 999.66x | -26.5x | -25.97x | -.--% | 10.07B | |
| 32.17x | - | -0.1x | 15.5x | 28.74x | 28.91x | -.--% | 8.79B | |
| 34.29x | 3.81x | 2.41x | 4.03x | 16.95x | 26.77x | 0.66% | 9.09B | |
| -14.35x | 470.64x | -0.28x | 8.86x | -14.46x | -13.62x | -.--% | 8.6B | |
| -29.47x | 7.59x | 5.99x | 83.88x | -18.91x | -18.38x | -.--% | 8.51B | |
| -20.25x | 7.66x | -1.58x | 3467.39x | -17.04x | -16.6x | -.--% | 8.58B | |
| 19.27x | 2.26x | 1.8x | 4.29x | 11.28x | 14.69x | -.--% | 8.56B | |
| -96.15x | 4.31x | 0.71x | 4.91x | 22.79x | 262.4x | -.--% | 8.22B | |
| Average | 6.78x | 34.37x | -1.08x | 282.64x | 5.76x | 20.49x | 0.2% | 18.14B | |
| Weighted average by Cap. | 15.23x | 20.20x | -2.26x | 174.71x | 8.64x | 17.52x | 0.27% |
Select your edition
All financial news and data tailored to specific country editions
